Literature DB >> 15547302

Serum sphingomyelin levels are related to the clearance of postprandial remnant-like particles.

Axel Schlitt1, Mohammad R Hojjati, Hans von Gizycki, Karl J Lackner, Stefan Blankenberg, Bernhard Schwaab, Juergen Meyer, Hans J Rupprecht, Xian-Cheng Jiang.   

Abstract

It is known that sphingomyelin (SM) content is higher in apolipoprotein B-containing particles (BLps) than in high density lipoproteins and that BLp levels, including chylomicrons and their remnant particles, are positively related to atherosclerosis. To evaluate the relationship between serum SM and postprandial remnant particle levels, we determined SM, triglyceride (TG), and cholesterol levels in serum and in remnant-like particles (RLPs) before and 3, 5, 7, and 10 h after a high-fat meal in 31 healthy subjects. We found that serum SM, like serum TG, was increased to its maximum 3 h after fat loading and then gradually decreased to basal levels after 10 h. More important, we determined that SM and TG levels in RLPs were parallel. Serum SM was positively correlated with serum TG (P <0.001), RLP SM (P <0.001), RLP TG (P <0.001), and RLP cholesterol (P <0.001) levels. It is our conclusion that serum SM is a marker for the clearance of RLPs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15547302     DOI: 10.1194/jlr.C400011-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  9 in total

1.  Lipid abnormalities in alpha/beta2-syntrophin null mice are independent from ABCA1.

Authors:  Tobias Hebel; Kristina Eisinger; Markus Neumeier; Lisa Rein-Fischboeck; Rebekka Pohl; Elisabeth M Meier; Alfred Boettcher; Stanley C Froehner; Marvin E Adams; Gerhard Liebisch; Sabrina Krautbauer; Christa Buechler
Journal:  Biochim Biophys Acta       Date:  2015-01-24

2.  Serum sphingolipids: relationships to insulin sensitivity and changes with exercise in humans.

Authors:  Bryan C Bergman; Joseph T Brozinick; Allison Strauss; Samantha Bacon; Anna Kerege; Hai Hoang Bui; Phil Sanders; Parker Siddall; Ming Shang Kuo; Leigh Perreault
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-06-30       Impact factor: 4.310

3.  Postprandial lipemia enhances the capacity of large HDL2 particles to mediate free cholesterol efflux via SR-BI and ABCG1 pathways in type IIB hyperlipidemia.

Authors:  Zélie Julia; Emilie Duchene; Natalie Fournier; Natacha Bellanger; M John Chapman; Wilfried Le Goff; Maryse Guerin
Journal:  J Lipid Res       Date:  2010-08-16       Impact factor: 5.922

4.  Macrophage sphingomyelin synthase 2 deficiency decreases atherosclerosis in mice.

Authors:  Jing Liu; Chongmin Huan; Mahua Chakraborty; Hongqi Zhang; Da Lu; Ming-Shang Kuo; Guoqing Cao; Xian-Cheng Jiang
Journal:  Circ Res       Date:  2009-07-09       Impact factor: 17.367

5.  Milk phospholipid and plant sterol-dependent modulation of plasma lipids in healthy volunteers.

Authors:  Sylvia Keller; Angelika Malarski; Carolin Reuther; Romy Kertscher; Michael Kiehntopf; Gerhard Jahreis
Journal:  Eur J Nutr       Date:  2012-07-27       Impact factor: 5.614

6.  Serum phospholipid transfer protein activity after a high fat meal in patients with insulin-treated type 2 diabetes.

Authors:  Axel Schlitt; Bernhard Schwaab; Kirsten Fingscheidt; Karl J Lackner; Gunnar H Heine; Alexander Vogt; Michael Buerke; Lars Maegdefessel; Uwe Raaz; Karl Werdan; Xian-Cheng Jiang
Journal:  Lipids       Date:  2010-01-27       Impact factor: 1.880

7.  Impact of sphingomyelin levels on coronary heart disease and left ventricular systolic function in humans.

Authors:  Xueying Chen; Aijun Sun; Yunzeng Zou; Junbo Ge; Jason M Lazar; Xian-Cheng Jiang
Journal:  Nutr Metab (Lond)       Date:  2011-04-26       Impact factor: 4.169

8.  A phospholipidomic analysis of all defined human plasma lipoproteins.

Authors:  Monireh Dashti; Willem Kulik; Frans Hoek; Enno C Veerman; Maikel P Peppelenbosch; Farhad Rezaee
Journal:  Sci Rep       Date:  2011-11-07       Impact factor: 4.379

9.  Further evaluation of plasma sphingomyelin levels as a risk factor for coronary artery disease.

Authors:  Axel Schlitt; Stefan Blankenberg; Daoguang Yan; Hans von Gizycki; Michael Buerke; Karl Werdan; Christoph Bickel; Karl J Lackner; Juergen Meyer; Hans J Rupprecht; Xian-Cheng Jiang
Journal:  Nutr Metab (Lond)       Date:  2006-01-05       Impact factor: 4.169

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.